Enterprise Value
0.00
Cash
104.8M
Avg Qtr Burn
-64.46M
Short % of Float
0.00%
Insider Ownership
14.63%
Institutional Own.
22.19%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
Pepaxto (Melflufen) Details Multiple myeloma | Phase 3 Update |